Heterocyclic compounds
US6329381A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | May 26, 2000 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | May 26, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a heterocyclic compound of the following general formula (I): ##STR1## PA1 wherein X is sulfur atom, oxygen atom or --NR.sup.3 -- (R.sup.3 may form a heterocyclic ring or a substituted heterocyclic ring with R.sup.1 via the nitrogen atom), PA1 R.sup.1 is alkyl group, substituted alkyl group, aryl group, substituted aryl group, heterocyclic group or substituted heterocyclic group, and PA1 R.sup.2 is hydrogen atom, halogen atom etc.; or its pharmaceutically acceptable salt and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases comprising the compound (I) or its pharmaceutically acceptable salt as active ingredients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.